ShopMedMen Oh Hell Yea..... I own some stock LetsDoThis
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pot sector falls into correction territory, but MedMen jumps after $682 million acquisitionMarijuana stocks were mostly lower Thursday, with a key sector tracker falling into correction territory, but MedMen Enterprises Inc. was a standout gainer after the company announced a $682 million acquisition of U.S.-based medical cannabis dispensary PharmaCann LLC. CRON up 8% and ACBFF up 5%. You ain’t smoking weed🌬😳 Igc
Lire la suite »
Marijuana stocks to watch: MedMen’s vision becomes reality with largest-ever U.S. pot mergerMedMen Enterprises co-founder Adam Bierman believes the company’s $682 million acquisition of PharmCann last week marks the culmination of the U.S. cannabis industry’s transformation from vision to reality.
Lire la suite »
Marijuana stocks to watch: MedMen turns a vision into reality with largest-ever U.S. pot mergerMedMen Enterprises co-founder Adam Bierman believes the company’s $682 million acquisition of PharmCann last week marks the culmination of the U.S. cannabis industry’s transformation from vision to reality. Ticker isn’t on robinhood?
Lire la suite »
The CEO of the biggest cannabis company in the US reveals his strategy for defending against multi-billion private equity fundsBI PRIME: Hot off of a $682 million acquisition, Adam Bierman, the CEO of MedMen — now the biggest cannabis company in the US — opens up about who his biggest competition is and how he's defending against them.
Lire la suite »
'Retail is the place to be' in cannabis, says MedMen CEO after 'blockbuster' PharmaCann acquisitionJim Cramer sits down with MedMen co-founder and CEO Adam Bierman, whose cannabis retailer will absorb PharmaCann in the largest marijuana-related acquisition in U.S. history.
Lire la suite »
A competitor is emerging to challenge the marijuana retail chain dominating the industry, and it just closed a $640 million acquisitionBI PRIME: iAnthus, a multistate cannabis dispensary operator, acquired Toronto-based MPX Bioceutical in a $640 million all-stock transaction. The deal comes on the heels of rival MedMen's $682 million acquisition of PharmaCann. BIPrime Are they considering a 'joint' venture?
Lire la suite »
Cannabis industry shops for a suit and tieMoney is pouring into weed as valuations rise and legal barriers fall – nudged further by recent U.S. election results. Companies like Canopy, Aurora and MedMen are starting to take on a veneer of acceptability. That doesn’t make them good investments, but it’s progress.
Lire la suite »
Pot sector falls into correction territory, but MedMen jumps after $682 million acquisitionMarijuana stocks were mostly lower Thursday, with a key sector tracker falling into correction territory, but MedMen Enterprises Inc. was a standout gainer after the company announced a $682 million acquisition of U.S.-based medical cannabis dispensary PharmaCann LLC. CRON up 8% and ACBFF up 5%. You ain’t smoking weed🌬😳 Igc
Lire la suite »